Skip to main content

Letrozole 13C2 15N2

MI8389

Letrozole 13C2 15N2

Price and Availability

Letrozole 13C2 15N2 for quantification:

Letrozole, a non-steroidal reversible aromatase inhibitor, is employed in the treatment of hormone receptor-positive breast cancer. For the bioanalysis of letrozole, the stable isotope-labeled compound Letrozole ¹³C₂-¹⁵N₂ serves as an ideal internal standard due to its structural and physicochemical similarity to the analyte. The quantification of letrozole was performed using a validated LC-MS/MS method, with chromatographic and mass spectrometric parameters adapted from a previously published protocol to ensure specificity and sensitivity.

Contact

Do you have any questions? 
Then contact us. We are happy to advise you in person!

Mon-Fri 9:00 - 12:00, 14:00 - 18:00 
For Chemical Compounds
+33 (0)5 49 45 41 21 
contact@artmolecule.fr

Information

All prices do not include VAT, shipping costs, and possibly applicable fees. Prices may deviate for certain countries, product lines, and hazardous materials classes. Products in the website are checked regularly in regard to price, availability, classification, and specification and kept up to date as best as possible. Changes may occur between updates. Subject to sale. Please contact us in order to see current availabilities.

Notice

Our products are produced by chemical synthesis and does not contain any animal or cell culture derived products or additives such as albumin or serum. (Contains no animal by-products). Products are intended for laboratory use only aned are offer exclusively toward companies, legal entities under public law or public-law special funds. Your complete company data is required for purchasing chemicals.

Products Send Email